Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-08

Clinical Trial Update: Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy of the amlodipine/benazepril combination in hypertensive African-American patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Benazepril (Benazepril)
  • LOTREL (amlodipine besylate and benazepril hydrochloride)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED